Baroda BNP Paribas Health and Wellness Fund Direct Growth

Fund Overview

Fund Size

₹519 Cr

Expense Ratio

0.61%

ISIN

INF251K01VA5

Minimum SIP

₹1,000

Exit Load

1.00%

Inception Date

27 Jun 2025

About this fund

Baroda BNP Paribas Health and Wellness Fund Direct Growth is a Sector - Healthcare mutual fund schemes offered by Baroda BNP Paribas Mutual Fund. This fund has been in existence for 1 years, 2 months and 1 days, having been launched on 27-Jun-25.
As of 27-Aug-26, it has a Net Asset Value (NAV) of ₹11.06, Assets Under Management (AUM) of 519.48 Crores, and an expense ratio of 0.61%.

Baroda BNP Paribas Health and Wellness Fund Direct Growth has given a CAGR return of 9.01% since inception.
The fund's asset allocation comprises around 96.61% in equities, 0.00% in debts, and 3.39% in cash & cash equivalents.
You can start investing in Baroda BNP Paribas Health and Wellness Fund Direct Growth with a SIP of ₹1000 or a Lumpsum investment of ₹1000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+12.81%

+17.81% (Cat Avg.)

Since Inception

+9.01%

— (Cat Avg.)

Portfolio Summaryas of 31st July 2026

Equity	₹501.87 Cr	96.61%
Others	₹17.61 Cr	3.39%

Top Holdings

All Holdings

Equity

Debt & Others

Name	Type	Amount	Holdings
Sun Pharmaceuticals Industries Ltd	Equity	₹45.83 Cr	8.82%
Torrent Pharmaceuticals Ltd	Equity	₹44.57 Cr	8.58%
Divi's Laboratories Ltd	Equity	₹34.58 Cr	6.66%
Lupin Ltd	Equity	₹33.57 Cr	6.46%
Ipca Laboratories Ltd	Equity	₹29.71 Cr	5.72%
Apollo Hospitals Enterprise Ltd	Equity	₹27.77 Cr	5.35%
Laurus Labs Ltd	Equity	₹27.24 Cr	5.24%
Fortis Healthcare Ltd	Equity	₹23.63 Cr	4.55%
AstraZeneca Pharma India Ltd	Equity	₹21.06 Cr	4.05%
Glenmark Pharmaceuticals Ltd	Equity	₹17.87 Cr	3.44%
Dr. Lal PathLabs Ltd	Equity	₹16.19 Cr	3.12%
Mankind Pharma Ltd	Equity	₹16.05 Cr	3.09%
Aurobindo Pharma Ltd	Equity	₹15.8 Cr	3.04%
Aster DM Quality Care Ltd Ordinary Shares	Equity	₹13.15 Cr	2.53%
Zydus Lifesciences Ltd	Equity	₹12.85 Cr	2.47%
Emcure Pharmaceuticals Ltd	Equity	₹12.76 Cr	2.46%
Abbott India Ltd	Equity	₹12.51 Cr	2.41%
Net Receivables / (Payables)	Cash - Collateral	₹12.5 Cr	2.41%
Max Financial Services Ltd	Equity	₹11.77 Cr	2.27%
Acutaas Chemicals Ltd	Equity	₹11.19 Cr	2.15%
Concord Biotech Ltd	Equity	₹10.66 Cr	2.05%
Nephrocare Health Services Ltd	Equity	₹9.03 Cr	1.74%
Metropolis Healthcare Ltd	Equity	₹7.57 Cr	1.46%
Inventurus Knowledge Solutions Ltd	Equity	₹7.4 Cr	1.42%
Ajanta Pharma Ltd	Equity	₹7.28 Cr	1.40%
Gland Pharma Ltd	Equity	₹6.26 Cr	1.20%
Cipla Ltd	Equity	₹5.89 Cr	1.13%
Dr Reddy's Laboratories Ltd	Equity	₹5.74 Cr	1.11%
Medplus Health Services Ltd	Equity	₹5.64 Cr	1.09%
Clearing Corporation Of India Ltd	Cash - Repurchase Agreement	₹5.11 Cr	0.98%
Manipal Health Enterprises Ltd	Equity	₹5 Cr	0.96%
Procter & Gamble Health Ltd	Equity	₹3.3 Cr	0.64%

Allocation By Market Cap (Equity)

Other Allocation

Equity Sector

Debt & Others

Sector	Amount	Holdings
Healthcare	₹478.91 Cr	92.19%
Financial Services	₹11.77 Cr	2.27%
Basic Materials	₹11.19 Cr	2.15%

Risk & Performance Ratios

Fund Managers

Rohan Korde

Since May 2026

Ankeet Pandya

Since July 2026

Additional Scheme Detailsas of 31st July 2026

ISIN

INF251K01VA5

Expense Ratio

0.61%

Exit Load

1.00%

Fund Size

₹519 Cr

Age

1 year 2 months

Lumpsum Minimum

₹1,000

Fund Status

Open Ended Investment Company

Benchmark

BSE Healthcare TR INR

Investment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Capital Gains Taxation:

Dividend Taxation:

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund name	Expense Ratio	Exit Load	Fund size	1Y
Invesco India Pharma and Healthcare Fund Regular Growth Very High Risk	-	0.0%	-	-
Invesco India Pharma and Healthcare Fund Direct Growth Very High Risk	-	0.0%	-	-
DSP Nifty Healthcare ETF Very High Risk	0.3%	-	₹18.04 Cr	15.5%
Groww BSE Hospitals ETF Very High Risk	0.5%	-	₹131.38 Cr	-
Mirae Asset Nifty 500 Healthcare ETF Very High Risk	0.1%	-	₹13.99 Cr	-
Bandhan Healthcare Fund Direct Growth Very High Risk	0.8%	0.0%	₹319.40 Cr	-
Bandhan Healthcare Fund Regular Growth Very High Risk	2.1%	0.0%	₹319.40 Cr	-
Baroda BNP Paribas Health and Wellness Fund Direct Growth Very High Risk	0.6%	1.0%	₹519.48 Cr	12.8%
Baroda BNP Paribas Health and Wellness Fund Regular Growth Very High Risk	2.1%	1.0%	₹519.48 Cr	10.8%
Bajaj Finserv Healthcare Fund Regular Growth Very High Risk	2.6%	1.0%	₹376.77 Cr	22.7%
Bajaj Finserv Healthcare Fund Direct Growth Very High Risk	0.9%	1.0%	₹376.77 Cr	24.8%
PGIM India Healthcare Fund Direct Growth Very High Risk	0.9%	0.0%	₹111.64 Cr	26.6%
PGIM India Healthcare Fund Regular Growth Very High Risk	2.5%	0.0%	₹111.64 Cr	24.4%
WhiteOak Capital Pharma and Healthcare Fund Regular Growth Very High Risk	2.8%	0.0%	₹824.90 Cr	22.1%
WhiteOak Capital Pharma and Healthcare Fund Direct Growth Very High Risk	1.2%	0.0%	₹824.90 Cr	24.2%
DSP Nifty Healthcare ETF Regular Growth Very High Risk	0.2%	-	₹14.94 Cr	11.4%
Kotak Healthcare Fund Direct Growth Very High Risk	0.9%	0.0%	₹682.39 Cr	28.1%
Kotak Healthcare Fund Regular Growth Very High Risk	2.4%	0.0%	₹682.39 Cr	26.1%
HDFC Pharma and Healthcare Fund Regular Growth Very High Risk	2.2%	1.0%	₹2939.98 Cr	26.1%
HDFC Pharma and Healthcare Fund Direct Growth Very High Risk	1.1%	1.0%	₹2939.98 Cr	27.6%
Nippon India Pharma Fund Direct Growth Very High Risk	0.8%	1.0%	₹9279.11 Cr	13.2%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Regular Growth Very High Risk	2.1%	1.0%	₹6802.61 Cr	9.4%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth Very High Risk	1.3%	1.0%	₹6802.61 Cr	10.3%
DSP Healthcare Fund Direct Growth Very High Risk	0.7%	0.0%	₹3639.29 Cr	18.0%
DSP Healthcare Fund Regular Growth Very High Risk	2.0%	0.0%	₹3639.29 Cr	16.5%
LIC MF Healthcare Fund Direct Growth Very High Risk	1.4%	1.0%	₹97.66 Cr	18.4%
LIC MF Healthcare Fund Regular Growth Very High Risk	2.7%	1.0%	₹97.66 Cr	16.9%
quant Healthcare Fund Direct Growth Very High Risk	1.5%	1.0%	₹397.15 Cr	25.2%
quant Healthcare Fund Regular Growth Very High Risk	3.1%	1.0%	₹397.15 Cr	23.2%
UTI Healthcare Fund Direct Growth Very High Risk	1.3%	1.0%	₹1370.92 Cr	18.3%
SBI Healthcare Opportunities Fund Direct Growth Very High Risk	1.0%	0.0%	₹5399.88 Cr	22.3%
Tata India Pharma & Healthcare Fund Regular Growth Very High Risk	2.3%	0.0%	₹1541.42 Cr	9.8%
Tata India Pharma & Healthcare Fund Direct Growth Very High Risk	1.0%	0.0%	₹1541.42 Cr	11.4%
ICICI Prudential Nifty Healthcare ETF Very High Risk	0.1%	-	₹235.16 Cr	15.6%
SBI Healthcare Opportunities Fund Regular Growth Very High Risk	2.0%	0.0%	₹5399.88 Cr	21.1%
Nippon India Pharma Fund Regular Growth Very High Risk	1.5%	1.0%	₹9279.11 Cr	12.2%
UTI Healthcare Fund Regular Growth Very High Risk	2.2%	1.0%	₹1370.92 Cr	17.2%
Axis NIFTY Healthcare ETF Very High Risk	0.4%	-	₹24.81 Cr	15.3%
Nippon India Nifty Pharma ETF Very High Risk	0.2%	-	₹1691.41 Cr	22.5%
Mirae Asset Healthcare Fund Regular Growth Very High Risk	1.6%	1.0%	₹3442.28 Cr	19.4%
Mirae Asset Healthcare Fund Direct Growth Very High Risk	0.5%	1.0%	₹3442.28 Cr	21.1%
ITI Pharma and Healthcare Fund Regular Growth Very High Risk	2.7%	0.0%	₹262.84 Cr	12.8%
ITI Pharma and Healthcare Fund Direct Growth Very High Risk	1.0%	0.0%	₹262.84 Cr	14.9%
Aditya Birla Sun Life Nifty Healthcare ETF Very High Risk	0.2%	-	₹82.10 Cr	15.5%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth Very High Risk	1.9%	1.0%	₹1073.85 Cr	17.5%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth Very High Risk	0.8%	1.0%	₹1073.85 Cr	19.1%
Motilal Oswal S&P BSE Healthcare ETF Very High Risk	0.4%	-	₹44.16 Cr	16.8%

About the AMC

Baroda BNP Paribas Mutual Fund

+91 22 69209600

https://www.barodabnpparibasmf.in/

Total AUM

₹53,349 Cr

Address

Crescenzo, 7th Floor, G-Block, Mumbai, 400 051

Other Funds by Baroda BNP Paribas Mutual Fund

Fund name	Expense Ratio	Exit Load	Fund size	1Y
Baroda BNP Paribas Services Fund Direct Growth Very High Risk	-	1.0%	-	-
BARODA BNP PARIBAS ESG Best-in-Class Strategy FUND Direct Growth Very High Risk	0.6%	1.0%	₹623.29 Cr	-
Baroda BNP Paribas Business Conglomerates Fund Direct Growth Very High Risk	0.7%	1.0%	₹664.62 Cr	-
Baroda BNP Paribas Gold ETF Fund Of Fund Direct Growth High Risk	0.1%	1.0%	₹179.05 Cr	52.8%
Baroda BNP Paribas Health and Wellness Fund Direct Growth Very High Risk	0.6%	1.0%	₹519.48 Cr	12.8%
Baroda BNP Paribas Multi Asset Active Fund of Funds Regular Growth Moderately High risk	0.2%	1.0%	₹115.05 Cr	14.6%
Baroda BNP Paribas Income Plus Arbitrage Active Fund of Fund Direct Growth Moderate Risk	0.1%	0.0%	₹80.71 Cr	6.3%
Baroda BNP Paribas Energy Opportunities Fund Direct Growth Very High Risk	1.1%	1.0%	₹645.01 Cr	5.7%
Baroda BNP Paribas Children's Fund Direct Growth Very High Risk	0.9%	1.0%	₹126.19 Cr	9.5%
Baroda BNP Paribas NIFTY Midcap 150 Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹10.24 Cr	11.2%
Baroda BNP Paribas Nifty200 Momentum 30 Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹21.76 Cr	4.0%
Baroda BNP Paribas Dividend Yield Fund Direct Growth Very High Risk	1.0%	1.0%	₹603.15 Cr	7.0%
Baroda Bnp Paribas Manufacturing Fund Direct Growth Very High Risk	1.0%	1.0%	₹846.24 Cr	19.5%
Baroda BNP Paribas Retirement Fund Direct Growth Very High Risk	0.9%	0.0%	₹401.35 Cr	8.4%
Baroda BNP Paribas Innovation Fund Direct Growth Very High Risk	0.9%	1.0%	₹894.31 Cr	15.1%
Baroda BNP Paribas NIFTY 50 Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹55.07 Cr	-1.8%
Baroda BNP Paribas Small Cap Fund Direct Growth Very High Risk	0.8%	1.0%	₹1287.55 Cr	13.8%
Baroda BNP Paribas Aqua Fund of Fund Direct Growth Very High Risk	0.5%	1.0%	₹58.69 Cr	16.4%
Baroda BNP Paribas Overnight Fund Direct Growth Low Risk	0.1%	0.0%	₹557.32 Cr	5.3%
Baroda BNP Paribas Business Cycle Fund Direct Growth Very High Risk	0.8%	1.0%	₹563.59 Cr	8.0%
Baroda BNP Paribas Multi Asset Fund Direct Growth High Risk	0.8%	1.0%	₹1463.69 Cr	12.7%
Baroda BNP Paribas Floater Fund Direct Growth Moderate Risk	0.2%	0.0%	₹17.70 Cr	8.8%
Baroda BNP Paribas Banking and PSU Bond Fund Direct Growth Moderate Risk	0.4%	0.0%	₹26.92 Cr	8.2%
Baroda BNP Paribas Banking and Financial Services Fund Direct Growth Very High Risk	0.7%	1.0%	₹436.71 Cr	9.4%
Baroda BNP Paribas Gilt Fund Direct Growth Moderate Risk	0.1%	0.0%	₹638.36 Cr	4.8%
Baroda BNP Paribas Multi Cap Fund Direct Growth Very High Risk	0.8%	1.0%	₹3432.00 Cr	7.3%
Baroda BNP Paribas Liquid Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹12206.26 Cr	6.4%
Baroda BNP Paribas Corporate Bond Fund Direct Growth Moderate Risk	0.2%	0.0%	₹269.54 Cr	6.5%
Baroda BNP Paribas Large Cap Fund Direct Growth Very High Risk	0.7%	1.0%	₹2632.10 Cr	4.5%
Baroda BNP Paribas Dynamic Bond Fund Direct Growth Moderate Risk	0.6%	0.0%	₹115.85 Cr	4.2%
Baroda BNP Paribas Mid Cap Fund Direct Growth Very High Risk	0.5%	1.0%	₹2584.12 Cr	15.7%
Baroda BNP Paribas Conservative Hybrid Fund Direct Growth Moderate Risk	0.4%	1.0%	₹944.15 Cr	6.7%
Baroda BNP Paribas Low Duration Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹390.70 Cr	6.5%
Baroda BNP Paribas ELSS Fund Direct Growth Very High Risk	0.9%	0.0%	₹917.16 Cr	9.4%
Baroda BNP Paribas Short Duration Fund Direct Growth Low to Moderate Risk	0.4%	0.0%	₹255.80 Cr	5.8%
Baroda BNP Paribas Balanced Advantage Fund Direct Growth Very High Risk	0.6%	1.0%	₹5166.21 Cr	10.2%
Baroda BNP Paribas Money Market Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹3493.78 Cr	6.5%
Baroda BNP Paribas Aggressive Hybrid Fund Direct Growth Very High Risk	0.5%	1.0%	₹1252.02 Cr	4.6%
Baroda BNP Paribas Focused Fund Direct Growth Very High Risk	0.5%	1.0%	₹650.46 Cr	2.7%
Baroda BNP Paribas NIFTY SDL December 2028 Index Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹29.96 Cr	5.9%
Baroda BNP Paribas India Consumption Fund Direct Growth Very High Risk	0.6%	1.0%	₹1463.75 Cr	-1.6%
Baroda BNP Paribas Value Fund Direct Growth Very High Risk	1.0%	1.0%	₹1013.87 Cr	3.6%
Baroda BNP Paribas Credit Risk Fund Direct Growth Moderately High risk	0.7%	1.0%	₹177.69 Cr	7.0%
Baroda BNP Paribas Arbitrage Fund Direct Growth Low Risk	0.3%	0.0%	₹1125.22 Cr	6.3%
Baroda BNP Paribas Large & Mid Cap Fund Direct Growth Very High Risk	0.7%	1.0%	₹1828.72 Cr	7.6%
Baroda BNP Paribas Medium Duration Fund Direct Growth Moderate Risk	0.7%	1.0%	₹28.33 Cr	7.7%
Baroda BNP Paribas Equity Savings Fund Direct Growth Moderately High risk	1.1%	1.0%	₹285.81 Cr	7.0%
Baroda BNP Paribas NIFTY SDL December 2026 Index Fund Direct Growth Low Risk	0.2%	0.0%	₹88.97 Cr	6.0%
Baroda BNP Paribas Ultra Short Duration Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹649.03 Cr	6.6%
Baroda BNP Paribas Flexi Cap Fund Direct Growth Very High Risk	0.8%	1.0%	₹1263.42 Cr	6.8%

Risk Level

Your principal amount will be at Very High Risk

Take control of your wealth

Track and Analyse all your investments with Dezerv

Rated ★ 4.3+ on

Still got questions?
We're here to help.

What is the current NAV of Baroda BNP Paribas Health and Wellness Fund Direct Growth?

The NAV of Baroda BNP Paribas Health and Wellness Fund Direct Growth, as of 27-Aug-2026, is ₹11.06.

What is the portfolio composition of Baroda BNP Paribas Health and Wellness Fund Direct Growth?

The fund's allocation of assets is distributed as 96.61% in equities, 0.00% in bonds, and 3.39% in cash and cash equivalents.

Who manages the Baroda BNP Paribas Health and Wellness Fund Direct Growth?

The fund managers responsible for Baroda BNP Paribas Health and Wellness Fund Direct Growth are:-

Rohan Korde
Ankeet Pandya

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme-related documents carefully. The NAVs of the schemes may go up or down depending upon the factors and forces affecting the securities market including the fluctuations in the interest rates. The past performance of the mutual funds is not necessarily indicative of the future performance of the schemes. Investors are requested to review the prospectus carefully and obtain expert professional advice with regard to specific legal, tax and financial implications of the investment/participation in the scheme.

;

©2021-2026 Dezerv. All Rights Reserved

Dezerv Investments Pvt. Ltd. is a Portfolio Manager with SEBI Registration no. INP000007377, a member of BSE with SEBI Stock Broker Registration no. INZ000303136, and an Investment Manager to Category - I AIF-VCF-Angel Fund with SEBI Registration no. IN/AIF1/22-23/1066.

Mutual Fund distribution services are offered through Dezerv Distribution Services Pvt Limited, a wholly owned subsidiary with AMFI Registration No.: ARN -248439. **Mutual fund investments are subject to market risks, read all scheme related documents carefully.** Terms and conditions of the website are applicable. Privacy policy of the website is applicable.

Baroda BNP Paribas Health and Wellness Fund Direct Growth

Fund Overview